Eli Lilly
LLY
LLY
1,330 hedge funds and large institutions have $64.9B invested in Eli Lilly in 2018 Q1 according to their latest regulatory filings, with 94 funds opening new positions, 434 increasing their positions, 563 reducing their positions, and 119 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
18% less call options, than puts
Call options by funds: $316M | Put options by funds: $386M
21% less first-time investments, than exits
New positions opened: 94 | Existing positions closed: 119
23% less repeat investments, than reductions
Existing positions increased: 434 | Existing positions reduced: 563
Holders
1,330
Holding in Top 10
22
Calls
$316M
Puts
$386M
Top Buyers
| 1 | +$311M | |
| 2 | +$255M | |
| 3 | +$194M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$185M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$156M |
Top Sellers
| 1 | -$368M | |
| 2 | -$245M | |
| 3 | -$242M | |
| 4 |
LCOV
London Company of Virginia
Richmond,
Virginia
|
-$206M |
| 5 |
O
OrbiMed
New York
|
-$193M |